HIMSS TV is your Insider’s Guide to everything HIMSS. We are the world’s first online broadcasting network, focused on global innovation and how information and technology are driving change in healthcare.
  Home
HIMSS25 Europe will be hosted in Paris
EMEA

HIMSS25 Europe will be hosted in Paris

3:01

Hal Wolf, HIMSS president and CEO, reflects on an "electrifying" HIMSS24 Europe conference in Rome and the decision to head to Paris in June 2025.

Read More
Read Less

EMEA - Similar Videos View more in EMEA

6:25

Abu Dhabi invests in a precision medicine-driven future

Abu Dhabi Biobank’s Paul Downey says the organization aims to build a massive, long-term research resource tracking lifestyle, genetics and environment to enable personalized care for regional health challenges.

Abu Dhabi invests in a precision medicine-driven future
Abu Dhabi Biobank’s Paul Downey says the organization aims to build a massive, long-term research resource tracking lifestyle, genetics and environment to enable personalized care for regional health challenges.
6:25
23:38

Creating the digital backbone of global care

Dr. Gao Yujia of Singapore's National University Health System says that advanced connectivity isn't just about increasing speed but building a foundation for scalable, successful and truly connected global healthcare.

Creating the digital backbone of global care
Dr. Gao Yujia of Singapore's National University Health System says that advanced connectivity isn't just about increasing speed but building a foundation for scalable, successful and truly connected global healthcare.
23:38
10:54

Redefining aging as a treatable condition

Alex Aliper, Insilico Medicine's president, says that longevity progress is already being made, but that regulators need to classify aging as a disease and track its biomarkers to enable more therapeutic advances.

Redefining aging as a treatable condition
Alex Aliper, Insilico Medicine's president, says that longevity progress is already being made, but that regulators need to classify aging as a disease and track its biomarkers to enable more therapeutic advances.
10:54